By www.reportprimer.com
Global Ependymoma Market Research Report 2023 Story
87
$ 2900
Ependymoma Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Eli Lilly
Astellas
DNAtrix
Advantagene
Burzynski Research Institute
Direct Therapeutics
Cellectar Biosciences
Amgen
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
Novartis
NewLink Genetics